Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vimirogant in Healthy Volunteers and Psoriasis Patients
NCT02555709Phase 2Completed
- Sponsor
- Allergan
- Start
- Aug 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vimirogant in psoriasis, sponsored by Allergan. Started Aug 2015; status: completed.
02
Drugs
vimirogant
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT02555709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02555709.